WO1994010328A1 - Process for the isolation and purification of mevinolin - Google Patents

Process for the isolation and purification of mevinolin Download PDF

Info

Publication number
WO1994010328A1
WO1994010328A1 PCT/HU1993/000051 HU9300051W WO9410328A1 WO 1994010328 A1 WO1994010328 A1 WO 1994010328A1 HU 9300051 W HU9300051 W HU 9300051W WO 9410328 A1 WO9410328 A1 WO 9410328A1
Authority
WO
WIPO (PCT)
Prior art keywords
filtered
active ingredient
liquor
mevinolin
fermentation liquor
Prior art date
Application number
PCT/HU1993/000051
Other languages
French (fr)
Inventor
Vilmos KÉRI
Éva ILKO^'Y
Irma HO^'GYE
Antónia JEKKEL
Ilona Bagdi
Gábor AMBRUS
Attila Jakab
Attila Andor
Lajos DEÁK
István Szabó
János BÁLINI
Zsuzsanna Sheidl
Etelka Deli
Gyula Horváth
Csaba Szabó
Ildikó LÁNG
Imre SZÉKELY
Imre Moravcsik
Vera KOVÁCS
Szabolcs MÁTYÁS
Zsuzanna SZTÁRAY
László ESZENYI
Original Assignee
Biogal Gyógyszergyár Rt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogal Gyógyszergyár Rt filed Critical Biogal Gyógyszergyár Rt
Priority to DE4395515T priority Critical patent/DE4395515T1/en
Priority to DE4395515A priority patent/DE4395515C2/en
Publication of WO1994010328A1 publication Critical patent/WO1994010328A1/en
Priority to US09/578,587 priority patent/US6812007B1/en
Priority to US10/842,221 priority patent/US20060223150A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/62Carboxylic acid esters
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Definitions

  • This invention relates to a process for the isolation and purification of mevinolin from fermentation liquor.
  • Mevinolin (lovastatin, monacolin K, K 803) is a known antihypercholesterolemic agent, which can be produced by fermentation using either a microorganism belonging to the species Aspergillus terreus or different microorganisms identified as species belonging to the Monascus genus.
  • the isolation of the active ingredient is carried out either by extracting directly the fermentation liquor with a solvent or by extracting the filtered liquor and the biomass and subsequently purifying the crude product by chromatography.
  • the main disadvantage of the extraction method resides in the fact that the solvent dissolves, together with the active ingredient, a lot of concomitant contaminations rendering thereby the further purification more complicated and expensive.
  • the purification at a proper efficiency can be accomplished namely by a multistage column chromatographic method and subsequent re- crystallization.
  • the present invention aims at providing a process for the isolation of mevinolin from fermentation liquor which can be carried out more readily and more economically than the hitherto known processes and enables the preparation of the active ingredient in a quality suitable for pharmaceutical purposes.
  • the present invention is based on the recognition that the active ingredient can be separated at high efficiency directly from the filtrate of the fermentation liquor (hereinafter: filtered liquor) at a pH value between 4.5 and 1.0.
  • the crude product separated in this manner does not require to be purified by chromatography, as only a surprisingly slight amount of contamination separates to ⁇ gether with it. Thus a simple recrystallization is sufficient to obtain a product of suitable quality.
  • the active ingredient is dissolved from the biomass into the fermentation liquor at a pH value between 7.5 and 10.0, the biomass is filtered off, the crude product is separated from the filtered liquor at a pH value between 4.5 and 1.0 and purified by methods known per se, preferably by recrystallization.
  • the separation of the active ingredient has been investigated at different acidic pH values.
  • the pH range of 2.4 to 1.8, especially 2.2 to 2.0 has been found to be the most preferable.
  • bivalent or trivalent metal salts such as alkaline earth metal salts (CaCl2, MgCl2, MgS04) or earth metal salts [ (AI2 (SO4)3] .
  • Aliphatic alcohols having 1 to 4 carbon atom(s), glycols having 2 to 5 carbon atoms, secondary or tertiary amines having 1 to 3 carbon atom(s), alkyl acetates having 1 to 5 carbon atom(s), dimethyl-formamide, polyethylene glycol or polypropylene glycol may serve as additives.
  • Additive Active ingredient content of the filtered liquor ( ⁇ g/cm )
  • ethylene glycol and ethanol are particularly preferred.
  • the additives effect their favourable activity even when applied in as slight amount as 0.1 % by volume calculated upon the volume of the fermentation liquor, and even when applied in greater amounts they do not have an influence on the separation of the dissolved active ingredient.
  • the crude product can be purified by any known method, e.g. by a simple recrystallization. According to our experiments • it is preferable to carry out the re ⁇ crystallization from isobutyl acetate in such a manner that the solution of the substance in isobutyl acetate is washed with a weakly basic 2.5 w% ammonium sulfate solution adjusted to pH 8.5, the solvent phase is clarified with carbon, concentrated and the separated product is filtered off.
  • the advantages of the process according to the present invention are as follows: it renders possible the elimination of the extraction of both the fermentation liquor and the biomass from the technological procedure, the active ingredient separated from the filtered liquor at an acidic pH value is surprisingly pure, so it does not require to be purified by chromatography, but a simple recrystallization results in a product suitable for pharmaceutical purposes. Consequently the technological procedure is simple and can be accomplished economically, with a slight loss of substance (with a yield of higher than 90 %) .
  • the process according to the invention can be applied by starting from any aqueous fermentation liquor cultured by a microorganism bio-synthetizing mevinolin either as the open-chain hydroxy acid or as lactone.
  • the filtered aqueous precipitate was dissolved in 50 cm of isobutyl acetate, the aqueous phase was separated and the solvent phase was concentrated to 2.5 cm .
  • the concentrate was dissolved in 60 c ⁇ r of isobutyl acetate,
  • the biomass was then filtered off and suspended in 400 c ⁇ r of water containing 0.8 g of ethylene glycol.
  • the suspension was adjusted to a pH value between 8.5 and 9.0 with 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined.
  • Active ingredient content 99.7 % (HPLC).
  • Dihydromevinolin content 0.15 % (GC)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention relates to a process for the isolation of mevinolin by dissolving the active ingredient from the biomass into the fermentation liquor and subsequently separating it from the filtered fermentation liquor, which comprises carrying out the dissolution at a pH value between 7.5 and 10.0, preferably between 8.0 and 9.0, separating the active ingredient from the filtered liquor at a pH value between 4.5 and 1.0, preferably between 2.2 and 2.0, filtering and purifying it by methods known per se, preferably by recrystallization.

Description

PROCESS FOR THE ISOLATION AND PURIFICATION OF MEVINOLIN
This invention relates to a process for the isolation and purification of mevinolin from fermentation liquor.
Mevinolin (lovastatin, monacolin K, K 803) is a known antihypercholesterolemic agent, which can be produced by fermentation using either a microorganism belonging to the species Aspergillus terreus or different microorganisms identified as species belonging to the Monascus genus.
The isolation of the active ingredient is carried out either by extracting directly the fermentation liquor with a solvent or by extracting the filtered liquor and the biomass and subsequently purifying the crude product by chromatography.
For the extraction ethyl acetate, chloroform or benzene is used. The fermentation liquor contains partly the open- chain hydroxy acid form of mevinolin, that is 3,5- dihydroxy-7-[1,2,6,7,8,8a-hexahydro-2,6-dimethyl-8- -(2-methylbutyryloxy)-naphtalene-1-yl]-heptanoic acid. This compound is heated in toluene to be lactonized to mevinolin. The purification of the crude product containing mevinolin exclusively in the form of lactone is carried out by chromatography and subsequent recrystallization (US patent specification No. 4,319,039, Hungarian patent specifications No. 182,069, 182,075 and 187,296). According to US patent specifications Nos. 4,231,938 and 4,319,039 beside the extraction an XAD2 adsorption resin is also used for the isolation of mevinolin.
The main disadvantage of the extraction method resides in the fact that the solvent dissolves, together with the active ingredient, a lot of concomitant contaminations rendering thereby the further purification more complicated and expensive. The purification at a proper efficiency can be accomplished namely by a multistage column chromatographic method and subsequent re- crystallization.
Experiments have been carried out in order to compare the extraction method specified in Hungarian patent specification No. 187,296 to the method according to this invention for the isolation of mevinolin from fermentation liquor obtained by cultivation of an Aspergillus obscurus MV-1 holotype strain (deposition number: NCAIM (P)F 001189). The results of Example 1 prove that the product obtained from the fermentation liquor by extraction cannot be properly purified by recristalliztion. The preparation of a product suitable for pharmaceutical purposes requires further purification by column chromatographic methods.
The present invention aims at providing a process for the isolation of mevinolin from fermentation liquor which can be carried out more readily and more economically than the hitherto known processes and enables the preparation of the active ingredient in a quality suitable for pharmaceutical purposes. The present invention is based on the recognition that the active ingredient can be separated at high efficiency directly from the filtrate of the fermentation liquor (hereinafter: filtered liquor) at a pH value between 4.5 and 1.0. The crude product separated in this manner does not require to be purified by chromatography, as only a surprisingly slight amount of contamination separates to¬ gether with it. Thus a simple recrystallization is sufficient to obtain a product of suitable quality.
According to the process of the invention the active ingredient is dissolved from the biomass into the fermentation liquor at a pH value between 7.5 and 10.0, the biomass is filtered off, the crude product is separated from the filtered liquor at a pH value between 4.5 and 1.0 and purified by methods known per se, preferably by recrystallization.
The separation of the active ingredient has been investigated at different acidic pH values. The pH range of 2.4 to 1.8, especially 2.2 to 2.0 has been found to be the most preferable. Besides, it has been found that the separation of the active ingredient from the filtered liquor, and especially the filterability of the precipitate can be improved by the addition of bivalent or trivalent metal salts, such as alkaline earth metal salts (CaCl2, MgCl2, MgS04) or earth metal salts [ (AI2 (SO4)3] .
In order to support what has been said in the following Table data are given to show the active ingredient content of the filtered liquor after filtering off the active ingredient at different pH values in the presence of or without adding calcium chloride to the filtered liquor. The content of the active ingredient was determined by HPLC.
Active ingredient content of the filtered pH liquor ( g/cm3)
7,0 6,0 5.0 4.0 3.0 2.0 1.5 1.0
Figure imgf000005_0001
Taking into consideration that the majority of the active ingredient is bound to the biomass, both the efficiency of the dissolution into the fermentation liquor and the amount of the concomitant contaminations are of great importance.
Besides, it has also been recognized that by carrying out the dissolution of the active ingredient into the fermentation liquor at a pH value between 7.5 and 10.0, particularly , between 8.0 and 9.0 both the loss of substance and the amount of the concomitant contaminations can be reduced to a minimum.
According to our experiences the dissolution of the active ingredient can be enhanced by adding a slight amount of additives to the mixture. Aliphatic alcohols having 1 to 4 carbon atom(s), glycols having 2 to 5 carbon atoms, secondary or tertiary amines having 1 to 3 carbon atom(s), alkyl acetates having 1 to 5 carbon atom(s), dimethyl-formamide, polyethylene glycol or polypropylene glycol may serve as additives.
In the following Table the active ingredient content of the filtered liquor is shown before the separation of the active ingredient at pH 9.0 and after the filtration thereof at pH 2.0 both in the presence of and without adding additives.
Additive Active ingredient content of the filtered liquor (μg/cm )
1 % by vol. pH:9.0 pH: 2.0
Diethylamine 412 9.2
Triethylamine 423 10.5
Dimethylformamide 460 6.9
Methanol 429 7.9
Ethanol 455 11.2
Isopropanol 467 8.7
Ethylene glycol 467 5.1
Propylene glycol 450 10.2
Polypropylene glycol 369 19.1
Isobutyl acetate 258 8.8
Polyethylene glycol 431 11.8
ontrol (without additive) 193 8.6 From the data of the above Table it can be established that upon the addition of different additives the active ingredient content of the filtered liquor is higher than without using such additives. So the additives promote the dissolution of the active ingredient from the biomass into the fermentation liquor. At the same time it can also be seen that the additives do not have an influence on the separation, this latter can be performed at the same efficiency either in the presence of or without adding additives. The addition thereof is optionally reasonable, as they render the technological procedure simpler. In the presence of additives namely a single formation of a suspension from the biomass is sufficient, while without using additives this procedure has to be repeated in order to achieve the same efficiency.
For the purpose of additive ethylene glycol and ethanol are particularly preferred.
According to our experiences the additives effect their favourable activity even when applied in as slight amount as 0.1 % by volume calculated upon the volume of the fermentation liquor, and even when applied in greater amounts they do not have an influence on the separation of the dissolved active ingredient.
Concentration of ethanol Active ingredient content of the filtered
% by volume liquor (μg/cm3) pH: 9.0
0.1 400 0.5 425 1.0 455 5.0 447
10.0 441 15.0 434 20.0 430
Figure imgf000007_0001
The crude product can be purified by any known method, e.g. by a simple recrystallization. According to our experiments it is preferable to carry out the re¬ crystallization from isobutyl acetate in such a manner that the solution of the substance in isobutyl acetate is washed with a weakly basic 2.5 w% ammonium sulfate solution adjusted to pH 8.5, the solvent phase is clarified with carbon, concentrated and the separated product is filtered off.
The advantages of the process according to the present invention are as follows: it renders possible the elimination of the extraction of both the fermentation liquor and the biomass from the technological procedure, the active ingredient separated from the filtered liquor at an acidic pH value is surprisingly pure, so it does not require to be purified by chromatography, but a simple recrystallization results in a product suitable for pharmaceutical purposes. Consequently the technological procedure is simple and can be accomplished economically, with a slight loss of substance (with a yield of higher than 90 %) .
The process according to the invention can be applied by starting from any aqueous fermentation liquor cultured by a microorganism bio-synthetizing mevinolin either as the open-chain hydroxy acid or as lactone.
The invention is illustrated in detail by the following Examples of non-limiting character:
Example 1 Comparative experiment according to the extraction method specified in Hungarian patent specification No. 187,296
800 g of fermentation liquor cultured by an Aspergillus obscurus _MV-1 holotype strain (deposition number: NCAIM (P)F 001189) containing a total amount of 670 mg of mevinolin both as lactone and as hydroxy acid were adjusted to pH 4 with 20 wt% sulfuric acid solution. The liquor was than extracted with 400 cm3 of ethyl acetate. The organic phase containing the active ingredient was separated and the aqueous residue was extracted again with further 400 cπr of ethyl acetate. The
•*> ethyl acetate extracts were combined (760 cm , active ingredient content: 643 mg) , dried over anhydrous sodium sulfate and concentrated in vacuo. The concentrate was boiled in 100 cm3 of toluene for 2 hours. Then the undissolved particles were filtered off and washed successively with 50 cm3 of 5 wt% sodium hydrogen carbonate solution and
50 cm3 of water. The toluene solution was dried over anhydrous sodium sulfate and evaporated in vacuo. The active ingredient content of the thus-obtained 3.5 g of oily product amounted to 630 mg. In order to crystallization the oily product was dissolved by warming in 15 cπr of ethanol and allowed to stand at a temperature of 5°C for 24 hours. The product did not separate in crystalline form. The solvent was then removed and the oily product (3.5 g) was devided into two parts.
•*) 1.75 g of product was recrystallized from 6 cm of isobutyl acetate as specified in Example 2. The product did not separate in crystalline form.
The other portion of the product was subjected to column chromatography using a column filled with 20 g of Kieselgel 60 (0.063 to 0.2 mm) (height: 22 cm, diameter:
1.6 cm). The column was eluted with a 40:60 mixture of ethyl acetate and methylene chloride at a rate of 20 crrr/hour. The 6 to 10 fractions containing the active ingredient were combined, clarified with activated carbon, filtered and evaporated in vacuo to yield 260 mg of yellowish white solid residue, which was recrystallized from ethanol. The separated crystals were filtered through a G-4 sieve, washed with 10 cmJ of n-hexane and dried in vacuo at room temperature. Thus 180 mg of chromatographically pure mevinolin were obtained. The evaporation residue of the mother liquor obtained during the recrystallization was recrystallized again from ethanol to obtain further 35 mg of mevinolin. The quality of the product was the same as that of the" first generation.
Example 2
800 g of fermentation liquor cultured by an Aspergillus strain specified in Example 1 containing a total amount of 536 mg of mevinolin both as lactone and as hydroxy acid were diluted to 1200 g with water. Then the solution was kept at a pH value between 8.5 and 9.0 with 20 wt% potassium hydroxide solution under continuous stirring for 2 hours. The biomass was then filtered off and suspended twice in 400 cm each of water. The suspension was adjusted to a pH value between 8.5 and 9.0 with 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined. Thus 1900 cm of filtered liquor containing 530 mg of active ingredient were obtained. The liquor was then adjusted to pH 2.1 with 15 wt% sulfuric acid solution, under stirring. The separated precipitate was settled, filtered, suspended in 100 cm3 of a sulfuric acid solution adjusted to pH 2 and filtered again. The active ingredient concentration of the filtrate amounted to 12 μg\cm3.
The filtered aqueous precipitate was dissolved in 50 cm of isobutyl acetate, the aqueous phase was separated and the solvent phase was concentrated to 2.5 cm . The concentrate was dissolved in 60 cπr of isobutyl acetate,
•_> washed twice with 60 cm each of an aqueous ammonium sulfate solution adjusted to pH 8.5 with ammonium hydroxide, clarified with 0.5 g of carbon, concentrated to
•*>
10 cm , allowed to crystallize for 24 hours at 5°C, filtered and dried in vacuo. Thus 436 mg of mevinolin were isolated. Active ingredient content: 98.7 % (HPLC). From the combined mother liquors further 65 mg of mevinolin were obtained in a purity of 92.8 %.
The crude products were combined and recrystallized from ethanol. Thus 450 mg of product were isolated. Active ingredient content: 99.8 % (HPLC). Dihydromevinolin content: 0.17% (GC)
[a] 25D= +329.8° (c=0.5; acetonitrile)
Example 3
800 g of fermentation liquor cultured by an Aspergillus strain specified in Example 1 containing a total amount of 605 mg of mevinolin both as lactone and as hydroxy acid were diluted to 1200 g with water. Then 2,4 g of ethylene glycol were added to the mixture, and it was kept at a pH value between 8.5 and 9.0 by adding 20 wt% potassium hydroxide solution under continuous stirring for 2 hours.
3
The biomass was then filtered off and suspended in 400 cπr of water containing 0.8 g of ethylene glycol. The suspension was adjusted to a pH value between 8.5 and 9.0 with 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined. The thus-obtained 1470
3 cm of filtered liquor containing 600 mg of active ingredient were adjusted to pH 2.1 with 15 wt% phosphoric acid under stirring. The precipitate was settled for 4 hours. Further on the process specified in Example 2 was followed.
Thus 548 mg of mevinolin were isolated.
Active ingredient content: 99.7 % (HPLC). Dihydromevinolin content: 0.15 % (GC)
[σ] 25D= +329° (c=0.5; acetonitrile)
Example 4
800 g of fermentation liquor cultured by an Aspergillus strain specified in Example 1 containing a total amount of 575 mg of mevinolin both as lactone and as hydroxy acid were diluted to 1200 g with water. Then 2,4 g of ethylene glycol were added to the mixture, and the pH were kept at 9.0 to 9.5 „y adding 20 wt% potassium hydroxide solution under continuous stirring for 2 hours. The biomass was
3 then filtered off and suspended in 400 cπr of water. The suspension was adjusted to a pH value between 9.0 and 9.5 with 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined. Thus 1480 cm3 of filtered liquor containing 567 mg of active ingredient were obtained. Then 3.5 g of calcium chloride were added to it and the solution was adjusted to pH 2.1 with 15 wt% sulfuric acid solution under stirring. The separated precipitate was settled for 4 hours. Further on the process specified in Example 2 was followed, with the difference that the active ingredient was dissolved from
3 the precipitate with 120 cm of isobutyl acetate. Thus 527 mg of mevinolin were isolated. Active ingredient content: 99.2 % (HPLC). Dihydromevinolin content: 0.25% (GC) [a] 25D= +329.5° (c=0.5; acetonitrile)
Example 5
10000 g of fermentation liquor cultured by an Aspergillus strain specified in Example 1 containing a total amount of 4180 mg of mevinolin both as lactone and as hydroxy acid were diluted to 15000 g with water. Then 30 g of ethylene glycol were added to the mixture, and it was kept at a pH value between 8.0 and 8.5 by adding 20 wt% potassium hydroxide solution under continuous stirring for 2 hours. The biomass was then filtered off and suspended in 5 dm of water containing 10 g of ethylene glycol. The suspension was adjusted to a pH value between 8.0 and 8.5 with 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined. Thus 18200 cm of filtered liquor containing 4091 mg of active ingredient were obtained. Then 20 g of magnesium sulfate were added to the mixture and it was adjusted to pH 2.1 with 15 wt% sulfuric acid solution, under stirring. The separated
3 precipitate was settled, filtered, suspended in 1200 cm of an aqueous sulfuric acid solution adjusted to pH 2 and filtered again. The filtered aqueous precipitate was
3 dissolved in 600 cπr of isobutyl acetate, the aqueous phase was separated and the solvent phase was concentrated to 30 cm3. The concentrate was dissolved in 400 cm3 of
-3 isobutyl acetate, washed twice with 400 cm each of 2.5 wt% ammonium sulfate solution adjusted to pH 8.5 with ammonium hydroxide solution and clarified with 6 g of carbon by stirring for half an hour at room temperature.
3
The solution was concentrated to 80 cm , allowed to crystallize for 24 hours at 5°C, filtered and dried in vacuo. Further on the process specified in Example 2 was followed. Thus 3432 mg of mevinolin were isolated. Active ingredient content: 99.1% (HPLC). Dihydromevinolin content: 0.19 % (GC) [a] 25D= +328.9° (c=0.5; acetonitrile)
Example 6
100 kg of fermentation liquor cultured by an Aspergillus strain specified in Example 1 containing a total amount of 44,3 g of mevinolin both as lactone and as hydroxy acid were diluted to 150 kg with water. Then 300 g of ethylene glycol were added to the mixture, and it was kept at a pH value between 8.5 and 9.0 by adding 20 wt% potassium hydroxide solution under continuous stirring for 2 hours. The biomass was then filtered off and suspended in 50 kg of water containing 100 g of ethylene glycol. The suspension was adjusted to a pH value between 8.5 and 9.0 with a 20 wt% potassium hydroxide solution, filtered again and the filtrates were combined. Thus 183 kg of filtered liquor containing 42.9 g of active ingredient were obtained. Then 200 g of magnesium sulfate were added to it and the solution was adjusted to pH 2.1 with 15 wt% sulfuric acid solution, under stirring. The separated precipitate was settled filtered, suspended in 12 dm3 of a sulfuric acid solution adjusted to pH 2 and filtered again. The filtered aqueous precipitate was dissolved in 6
*3 dm of isobutyl acetate, the aqueous phase was separated and the solvent phase was concentrated to 300 cm3. The
3 concentrate was dissolved in 4 dm of isobutyl acetate, 3 washed twice with 4 dm each of 2.5 wt% ammonium' sulfate solution adjusted to pH 8.5 with ammonium hydroxide solution and clarified with 60 g of carbon by stirring for half an hour at room temperature. The solution was
3 concentrated to 0.8 dm , allowed to crystallize for 24 hours at 5βC, filtered and dried in vacuo. Further on the process according to Example 2 was followed. Thus 37.03 g of mevinolin were isolated. Active ingredient content:99.3% (HPLC). Dihydromevinolin content: 0.18 % (GC)
[ a] 25D= +329.5° (c=0.5; acetonitrile)

Claims

What we claim is:
1. A process for the isolation of mevinolin by dissolving the active ingredient from the biomass into the fermentation liquor and subsequently separating it from the filtered fermentation liquor, which comprises carrying out the dissolution at a pH value between 7.5 and 10.0, preferably between 8.0 and 9.0, separating the active ingredient from the filtered liquor at a pH value between 4.5 and 1.0, preferably between 2.2 and 2.0, filtering and purifying it by methods known per se, preferably by recrystallization.
2. A process as claimed in claim 1, which comprises carrying out the dissolution in the presence of any of the following additive(s) applied in an amount of at least 0.1 wt% related to the volume of the fermentation liquor: aliphatic alcohols having 1 to 4 carbon atom(s), glycols having 2 to 5 carbon atoms, secondary or tertiary amines having 1 to 3 carbon atom(s), alkyl acetates having 1 to 5 carbon atom(s), dimethylformamide and/or polyethylene glycol and/or polypropylene glycol.
3. A process as claimed in claim 2, which comprises using as additive ethanol or ethylene glycol.
4. A process as claimed in any of claims 1 to 3, which comprises adding an alkaline earth metal salt or an earth metal salt to the filtered liquor prior to the separation.
PCT/HU1993/000051 1992-11-04 1993-09-08 Process for the isolation and purification of mevinolin WO1994010328A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
DE4395515T DE4395515T1 (en) 1992-11-04 1993-09-08 Process for the isolation and purification of mevinolin
DE4395515A DE4395515C2 (en) 1992-11-04 1993-09-08 Process for the isolation and purification of mevinolin
US09/578,587 US6812007B1 (en) 1992-11-04 2000-04-19 Process for the isolation and purification of mevinolin
US10/842,221 US20060223150A1 (en) 1993-09-08 2004-05-10 Process for the isolation and purification of mevinolin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9203458A HU210867B (en) 1992-11-04 1992-11-04 Method for extraction and purification of mevinolin from culture medium
HUP9203458 1992-11-04

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US26915094A Continuation 1992-11-04 1994-06-30
US26915094A Continuation-In-Part 1992-11-04 1994-06-30

Publications (1)

Publication Number Publication Date
WO1994010328A1 true WO1994010328A1 (en) 1994-05-11

Family

ID=10982513

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/HU1993/000051 WO1994010328A1 (en) 1992-11-04 1993-09-08 Process for the isolation and purification of mevinolin

Country Status (8)

Country Link
AT (1) AT401060B (en)
CA (1) CA2127381C (en)
DE (2) DE4395515T1 (en)
ES (1) ES2081776B1 (en)
GR (1) GR930100408A (en)
HU (1) HU210867B (en)
IT (1) IT1266672B1 (en)
WO (1) WO1994010328A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029292A1 (en) * 1993-06-08 1994-12-22 Krka Tovarna Zdravil P.O. Process for the isolation of lovastatin
WO1997020834A1 (en) * 1995-12-06 1997-06-12 Antibiotic Co. Method of production of lovastatin
WO2000063411A1 (en) * 1999-04-16 2000-10-26 Biotika A.S. Process of isolation of lovastatin from fermentation broth
EP1263979A1 (en) * 2000-02-24 2002-12-11 Biogal Gyogyszergyar Rt. Method of purifying a fermentation broth
EP1265884A1 (en) * 2000-03-03 2002-12-18 Biogal Gyogyszergyar Rt. A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2204285B1 (en) * 2002-05-20 2005-03-01 Ercros Industrial, S.A. PROCEDURE FOR THE INSULATION AND PURIFICATION OF LOVASTATIN.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006216A1 (en) * 1979-02-20 1980-09-04 Sankyo Co NEW MONACOLIN K COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND
DE3006215A1 (en) * 1979-05-11 1980-11-27 Sankyo Co METHOD FOR PRODUCING MONACOLIN K

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR69216B (en) * 1979-06-15 1982-05-07 Merck & Co Inc
HU208997B (en) * 1992-06-17 1994-02-28 Gyogyszerkutato Intezet Microbiological method for producing mevinoline

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3006216A1 (en) * 1979-02-20 1980-09-04 Sankyo Co NEW MONACOLIN K COMPOUND, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND
DE3006215A1 (en) * 1979-05-11 1980-11-27 Sankyo Co METHOD FOR PRODUCING MONACOLIN K

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
PROC. NATL. ACAD. SCI. U.S.A., Volume 77, No. 7, Published July 1980, (Baltimore, USA), A.W. ALBERTS et al., "Mevindin: A Highly Potent Competitive Inhibitor of Hydroxymethylglutaryl-Coenzyme A Reductase and a Cholesterol-Lowering Agent", pages 3957-3961. *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994029292A1 (en) * 1993-06-08 1994-12-22 Krka Tovarna Zdravil P.O. Process for the isolation of lovastatin
US5712130A (en) * 1993-06-08 1998-01-27 Krka Tovarna Zdravil, P.O Process for the isolation of lovastatin
WO1997020834A1 (en) * 1995-12-06 1997-06-12 Antibiotic Co. Method of production of lovastatin
WO2000063411A1 (en) * 1999-04-16 2000-10-26 Biotika A.S. Process of isolation of lovastatin from fermentation broth
EP1263979A1 (en) * 2000-02-24 2002-12-11 Biogal Gyogyszergyar Rt. Method of purifying a fermentation broth
EP1263979A4 (en) * 2000-02-24 2003-05-21 Biogal Gyogyszergyar Method of purifying a fermentation broth
EP1265884A1 (en) * 2000-03-03 2002-12-18 Biogal Gyogyszergyar Rt. A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities
EP1265884A4 (en) * 2000-03-03 2003-05-21 Plus Chemical S A A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities

Also Published As

Publication number Publication date
AT401060B (en) 1996-06-25
CA2127381C (en) 1997-12-23
DE4395515C2 (en) 1999-06-17
CA2127381A1 (en) 1994-05-11
HU210867B (en) 1995-10-30
ATA901593A (en) 1995-10-15
ITMI932343A0 (en) 1993-11-04
IT1266672B1 (en) 1997-01-09
ES2081776B1 (en) 1996-10-16
ES2081776A1 (en) 1996-03-01
GR930100408A (en) 1994-07-29
ITMI932343A1 (en) 1995-05-04
DE4395515T1 (en) 1994-12-01

Similar Documents

Publication Publication Date Title
US6387258B1 (en) Method of purifying statins from a fermentation broth
CZ283540B6 (en) Lovastatin isolation process
HU212583B (en) New process for producing potassium salt of clavulanic acid
WO1994029292A9 (en) Process for the isolation of lovastatin
AU2001236543A1 (en) Method of purifying a fermentation broth
EP1265604B1 (en) Process for recovering statin compounds from a fermentation broth
US6825015B1 (en) Process for the obtaining of HMG-COA reductase inhibitors of high purity
WO1994010328A1 (en) Process for the isolation and purification of mevinolin
EP0005614A1 (en) Lithium pseudomonate, process for its isolation and its hydrolysis
WO2005082910A1 (en) Process for isolation of ergot alkaloids from ergot
US6812007B1 (en) Process for the isolation and purification of mevinolin
US20060223150A1 (en) Process for the isolation and purification of mevinolin
US20090156837A1 (en) Isolation and recovery of simvastatin in lactone form or in the form of an acid salt from the harvested fermentation broth
EP1673361B1 (en) A method for the manufacture of lovastatin
CA2425882A1 (en) Method of purifying pravastatin or its pharmacologically acceptable salt
US2898268A (en) Acid purification of fumagillin
CN114133331A (en) Method for recovering and obtaining high-purity pravastatin ester
RU2088586C1 (en) Method of preparing clavulanic acid or its pharmaceutically acceptable salts or esters
EP1481674B1 (en) Process for recovering statin compounds from a fermentation broth
CS239441B1 (en) Method of isolation and separation of alkaloids of agroklavine and elymoklavine
EP1798214A1 (en) Process for recovering statin compounds from a fermentation broth
BG62330B1 (en) Method for lovastatin preparation

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT CA DE ES US

ENP Entry into the national phase

Ref document number: 1993 9015

Country of ref document: AT

Date of ref document: 19940511

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 19939015

Country of ref document: AT

ENP Entry into the national phase

Ref document number: 9450018

Country of ref document: ES

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 009450018

Country of ref document: ES

Ref document number: P009450018

Country of ref document: ES

Ref document number: 2127381

Country of ref document: CA

RET De translation (de og part 6b)

Ref document number: 4395515

Country of ref document: DE

Date of ref document: 19941201

WWE Wipo information: entry into national phase

Ref document number: 4395515

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 9450018

Country of ref document: ES

Kind code of ref document: A

WWG Wipo information: grant in national office

Ref document number: 9450018

Country of ref document: ES

Kind code of ref document: A

WWX Former pct application expired in national office

Ref document number: 9450018

Country of ref document: ES

Kind code of ref document: A